|
Market Closed -
Australian S.E.
01:34:49 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.1500 AUD | 0.00% |
|
+3.45% | - |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 77 | - | - |
| Change | - | - | 343.99% | -36.14% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 59.1 | 53.6 | 59.6 |
| Change | - | - | 241.42% | -36.26% | -9.31% | 11.19% |
| P/E | -2.64x | -3.27x | -14.3x | -6.52x | -21.4x | -13.6x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.2x | 0.3x | -0.2x |
| Capitalization / Revenue | - | - | - | - | 8.1x | 8.1x |
| EV / Revenue | - | - | - | - | 5.64x | 6.27x |
| EV / EBITDA | - | - | -11.2x | -5.14x | -13.4x | -9.93x |
| EV / EBIT | - | - | -11.1x | -5.09x | -13.1x | -9.77x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1500 | 0.1500 | 0.1500 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 5/30/23 | 5/30/25 | 5/29/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.52x | - | -5.14x | - | 55.19M | |
| 21.45x | 7.54x | 15.37x | 1.38% | 72.12B | |
| 37.53x | 9.72x | 29.82x | 0.04% | 65.85B | |
| -18.08x | 7.59x | -9.85x | -.--% | 29.28B | |
| -79.5x | 14.86x | -71.64x | -.--% | 27.47B | |
| 33.76x | 6.66x | 17.64x | -.--% | 26.7B | |
| 27.2x | 5.1x | 17.12x | -.--% | 20.06B | |
| 52.91x | 19.58x | 39.65x | 0.29% | 18.22B | |
| 2460.33x | 41.28x | -5047.29x | -.--% | 16.4B | |
| 16.73x | 4.96x | 11.58x | -.--% | 13.4B | |
| Average | 254.58x | 13.03x | -500.28x | 0.19% | 28.95B | |
| Weighted average by Cap. | 152.98x | 11.04x | -277.26x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
